Loading…
Fierce JPM Week - Virtual Agenda has ended
avatar for Martin Meeson

Martin Meeson

FUJIFILM Diosynth Biotechnologies
CEO
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets.

Martin was named Chief Executive Officer on April 1st, 2020, after serving as Chief Operating Officer and President of our US FDB operations (North Carolina and Texas). Previously Martin served as Chief Financial Officer for the US. Prior to this, Martin worked for FUJIFILM Diosynth Biotechnologies for over 6 years, holding leadership positions at the United Kingdom site, including Head of Finance and IT. Before joining FUJIFILM Diosynth Biotechnologies he was Finance Director at Oxford Chemicals where he was responsible for all aspects of Finance, IT, and Purchasing. He also held leadership positions at Hibernia Foods, ICI/Dupont and KPMG.

My Speakers Sessions

Tuesday, January 18
 

11:30am EST

 
Wednesday, January 19
 

9:30am EST